Filing metadata

Accession number
0000902664-17-004240
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 08, 2017
Reporting period
Nov 08, 2017
Description
Initial ownership

Explore SEC Filings Hub